Archives

More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds​More than a quarter of adults worldwide could benefit from GLP-1 medications for weight loss, study finds 

The worldwide prevalence of obesity has more than doubled in the last three decades, bringing with it an increase in weight-related diseases like diabetes, cardiovascular disease, and cancers. This public health crisis strains global health care systems and economies, but a new study co-led by investigators from Mass General Brigham could inform strategic programs to Read More

STAT+: Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms​STAT+: Eli Lilly’s Zepbound, on top of immunology drug, helped reduce psoriatic arthritis symptoms 

Eli Lilly said Thursday that adding its weight loss drug Zepbound on top of its immunology therapy Taltz helped obese patients with an autoimmune condition that causes joint pain more than Taltz did alone. The data suggest the GLP-1 drug Zepbound, which has already been shown to help with obesity and sleep apnea, among other Read More

GLP-1 receptor agonists tied to reduced acute asthma exacerbations in teens with overweight, obesity​GLP-1 receptor agonists tied to reduced acute asthma exacerbations in teens with overweight, obesity 

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in adolescents with overweight or obesity, according to a research letter published online Dec. 29 in JAMA Network Open. ​Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a lower risk for acute asthma exacerbations in adolescents Read More

Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer, researchers discover​Cholesterol-lowering drug can overcome chemotherapy resistance in triple-negative breast cancer, researchers discover 

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and HER2 receptors and thus relying primarily on cytotoxic chemotherapy. Despite initial responsiveness, many patients experience rapid relapse driven by cancer stem-like cells that survive chemotherapy and seed metastasis.

Perceptions of GLP-1 RA Use for Children Among Caregivers With Food Insecurity​Perceptions of GLP-1 RA Use for Children Among Caregivers With Food Insecurity 

This qualitative study explores perceptions among caregivers who have food insecurity about use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for children with obesity and metabolic disease. ​This qualitative study explores perceptions among caregivers who have food insecurity about use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for children with obesity and metabolic disease.